Does GHK-Cu actually have human evidence?

Yes, more than most peptides in this cluster — but it is mostly small topical cosmetic studies on skin appearance, not trials of deep-tissue or systemic regeneration.

Is topical or injectable GHK-Cu better studied?

Topical, by a wide margin. Injectable GHK-Cu is essentially unstudied in humans, so the safety and efficacy of that route are unknown.

Human (observational)OTC supplement

GHK-Cu

Also known as: Copper Tripeptide-1, Copper Peptide, GHK Copper

A naturally occurring copper-binding tripeptide with the most direct human data in the Recovery cluster — but almost all of it is topical, cosmetic, and small-scale.

TopicalInjectableCAS 49557-75-7

Last updated June 19, 2026

The one compound in this cluster with real, direct human data — but look closely at what that data covers. It is mostly small topical skin-cream trials on firmness and wrinkles, several of them industry-linked. For deep-tissue or injected use, you are back in the unknown.

Mechanism

GHK is three amino acids — glycine, histidine, lysine — that grab onto copper to form the GHK-Cu complex. Levels drop as you age. In lab and skin studies it nudges collagen, elastin, and glycosaminoglycan production, supports wound healing, and shifts the activity of thousands of genes tied to tissue remodeling and repair. Nearly all of that work is on skin, for the simple reason that skin is where people have actually applied it.

What the research shows

GHK-Cu beats the rest of this cluster on human evidence — with a big asterisk. The human studies are mostly small, topical, cosmetic trials, often industry-adjacent, measuring how skin looks and feels rather than the deep-tissue, tendon, or systemic outcomes some buyers are chasing. Injectable use is essentially a blank in humans. The honest grade is narrow: solid enough for skin appearance, little to nothing for the bigger regenerative claims.

Evidence grade: Human (observational) — Human data from non-randomized studies: cohorts, case series, case reports.

Benefits studied

Firmer, more elastic skin in topical cosmetic trials
More collagen and glycosaminoglycan synthesis in skin studies
Wound-healing and tissue-remodeling activity in lab and animal models
Antioxidant and anti-inflammatory gene modulation in vitro

Risks & unknowns

Human evidence is mostly topical and cosmetic — systemic/injectable use is unstudied
Copper exposure from high or injected doses is a theoretical safety concern
Many positive studies are small or industry-linked
Topical irritation possible in sensitive individuals

Regulatory status

OTC supplement. Sold over the counter as a dietary supplement or cosmetic ingredient.

Goals studied: Skin anti-aging, Tendon & ligament repair

FAQ

Does GHK-Cu actually have human evidence?: Yes, more than most peptides in this cluster — but it is mostly small topical cosmetic studies on skin appearance, not trials of deep-tissue or systemic regeneration.
Is topical or injectable GHK-Cu better studied?: Topical, by a wide margin. Injectable GHK-Cu is essentially unstudied in humans, so the safety and efficacy of that route are unknown.

Sources

[1]
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Pickart L, Margolina A · International Journal of Molecular Sciences · 2018 · PMID 29986520 · model: in-vitro
Revue documentant la modulation par le GHK-Cu de milliers de gènes humains liés à la réparation tissulaire et à la défense antioxydante.
[2]
GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration
Pickart L, Vasquez-Soltero JM, Margolina A · BioMed Research International · 2015 · PMID 26236730 · model: in-vitro
Revue des effets du GHK sur le collagène, les fibroblastes et les voies de réparation cutanée à concentrations nanomolaires.